Envision Pharma ‘Visions In’ Series
The Envision Pharma Group
An essential part of this process is to develop and provide those companies we partner with our ‘Visions In’ Series of hand-outs. These concise fact sheets offer timely information on the most relevant topics in publication planning. Each hand-out begins with a scenario followed by a discussion section and key points, and provides a list of additional resources.
An essential part of this process is to develop and provide those companies we partner with our ‘Visions In’ Series of hand-outs. These concise fact sheets offer timely information on the most relevant topics in publication planning.
Each hand-out begins with a scenario followed by a discussion section and key points, and provides a list of additional resources.
The Visions In Publication Series covers the following topics:
Guide to ensure that Publication Committees follow Good Publication Practice for Communicating Company-Sponsored Medical Research (GPP2) so that clinical trials sponsored by pharmaceutical companies are published in a responsible and ethical manner.
Guide to ICMJE and the criteria for identifying who received author credit.
Guide to ensuring that contributions & participation by medical writers and other non-author individuals or groups to the development or content of clinical research and other medical and scientific publications are correctly acknowledged, whether originating from commercial, academic, or government research environments.
Guide to help teams proactively assemble all the necessary ingredients for writing a robust manuscript.
Guide to setting in place a process that seeks to improve the reporting of randomized clinical trials (RCTs).
Guide to creating a checklist to help standardize the reporting of clinical trials at congresses.
Guide to the proper utilization of Datavision™ to allow companies to compile all of the requested information in a single place and report on it as needed and facilitating professionally prepared packages of information to be supplied to any requestor.
Guide to PDUFA IV, which updates PDUFA III, has 2 significant revisions including expanding the types of clinical trials that must register on a public Web site and the creation of a new trial results database.
Guide to provide industry with a way to share appropriate off-label information with healthcare providers.
Guide to US copyright policy and the sharing of such material.
Guide to open-access publishing which aims to allow free and unrestricted access to publications via the Internet.
Guide to the role of secondary analyses and additional publication opportunities.
Guide to ethical and legal issues and roles and responsibilities in medical publications.
Guide to evidence-based medicine and the publication plan.
Guide to planning, managing, and tracking publications to prepare for audits, senior management reporting, and addressing external queries.
Guide to selecting journals and the publication landscape.
Guide to risk management and prevention.
Guide to defining those responsible for facilitating the timely development of publications.
Guide to Corporate Integrity Agreements.
Guide to effective use of metrics.